{
    "Trade/Device Name(s)": [
        "Quest Diagnostics HairCheck-DT (Amphetamines)"
    ],
    "Submitter Information": "Quest Diagnostics Incorporated",
    "510(k) Number": "K051161",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ"
    ],
    "Summary Letter Date": "October 31, 2005",
    "Summary Letter Received Date": "November 1, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamines test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine",
        "MDMA",
        "Amphetamines"
    ],
    "Specimen Type(s)": [
        "Hair (head)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Gas Chromatography-Mass Spectrometry (GC/MS)",
        "GC/MS/MS"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Selected ion monitoring (SIM)",
        "Selected reaction mode (SRM)"
    ],
    "Submission Type(s)": [
        "Test",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Quest Diagnostics HairCheck-DT (Amphetamines) for qualitative detection of amphetamines in head hair samples using ELISA and GC/MS confirmation.",
    "Indications for Use Summary": "Qualitative detection of amphetamines at or above 300 pg/mg in head hair for identifying chronic methamphetamine and MDMA use; for in-house professional use only and not for sale.",
    "fda_folder": "Toxicology"
}